Skip to evidence report

GRNLSA.p53_damage: Studies — page 12

How association tiers are defined — cell–trait and gene–trait

SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.

Cell–trait tiers

Cell–trait links
Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
Required for Specific or Relevant
The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
Specific (Tier 1)
Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
Relevant (Tier 2)
Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
Interpretation and report values
CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
Meta traits and individual traits
Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.

Gene–trait priorities (variant–tCRE–gene evidence)

Variant–tCRE–gene links
Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
Required genetic support
The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
Required cellular support
The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
High priority
Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
Medium priority
Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
Same-record evidence and aggregation
Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
Limits of interpretation
A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.

State · 297 full-atlas cells · all tissues.

Marker genes and cell annotation · Open this population in Cell Browser →

ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.

Rows 11,001–12,000 of 12,313; ranked by score descending. Equal values use name/identifier order.

Studies ranked for GRNLSA.p53_damage
#Trait / studyIndividual trait IDMean IC score
11001CLEC4D/HGF ratioGCST903141102.30e-04
11002PLA2G4A/SPINT2 ratioGCST903156712.29e-04
11003CD40/TIMP3 ratioGCST903138292.29e-04
11004TNFRSF13B/TNFRSF13C ratioGCST903159312.28e-04
11005EDAR/TMSB10 ratioGCST903145902.27e-04
11006NAA80 levelsGCST904699902.27e-04
11007MME/NT5E ratioGCST903154602.27e-04
11008CD38/IL12A_IL12B ratioGCST903138082.26e-04
11009Cancer of prostate (PheCode 185)GCST904755912.26e-04
11010CXCL17/LAMP3 ratioGCST903143402.25e-04
11011SPARC/TACC3 ratioGCST903158722.25e-04
11012aparc-a2009s rh area S-parieto-occipitalGCST900034352.24e-04
11013Qualifications - NVQ or HND or HNC or equivalent | EducationUKBB000007302.24e-04
11014Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers)FING000007522.24e-04
11015SMOC2 levelsGCST904227732.24e-04
11016Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T32ECGU0000322.24e-04
11017EIF4G1/NFATC1 ratioGCST903146372.23e-04
11018Left-hemisphere limbic network to caudate white-matter structural connectivityGCST903027372.23e-04
11019aparc-DKTatlas lh area lingualGCST900032452.22e-04
11020Asthma-related pneumoniaFING000001192.21e-04
11021Lymphoid neoplasms (B-cell phenocluster)GCST906247362.20e-04
11022CCN2/SPINT2 ratioGCST903137162.18e-04
11023TOR1AIP1 levelsGCST904709352.18e-04
11024PDGFB/PPP1R12A ratioGCST903156232.18e-04
11025Varicose veinsFING000014162.18e-04
11026SPARC/TJAP1 ratioGCST903158732.17e-04
11027ECG, heart rate | ECG during exerciseUKBB000002042.17e-04
11028ALB/Globulin ratioUKBB000000202.16e-04
11029Asthma (childhood onset)GCST0078002.15e-04
11030IDP T1 FAST ROIs R cerebellum IXGCST900025862.15e-04
11031C19ORF12 levelsGCST904684832.14e-04
11032Systolic blood pressureGCST904727812.14e-04
11033CXADR/MME ratioGCST903143292.13e-04
11034Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T22ECGU0000222.13e-04
11035T1 FreeSurfer BA lh BA4p exvivo thicknessGCST903855242.12e-04
11036T1 FIRST volume BrStemGCST903839892.11e-04
11037T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 12)GCST903208312.11e-04
11038Attention deficit hyperactivity disorder (ADuLT model adjusted for sex)GCST902751362.10e-04
11039Prostate cancerGCST902747162.10e-04
11040aparc-Desikan lh area lingualGCST900030852.10e-04
11041Cerebral aneurysmGCST900185952.10e-04
11042Frequency of walking for pleasure in last 4 weeks | Physical activityUKBB000002712.09e-04
11043GZMH/KLRD1 ratioGCST903150162.08e-04
11044BIN2 levelsGCST904684452.07e-04
11045Body mass index (BMI, maximum, inv-normal transformed)GCST904751532.07e-04
11046BACH1/PDLIM7 ratioGCST903134452.06e-04
11047hemoglobin (mean, inv-norm transformed)GCST904753742.06e-04
11048Symptoms involving digestive system (PheCode 561)GCST904760692.05e-04
11049TJAP1 levelsGCST904708742.05e-04
11050Dry age-related macular degeneration (includes geographic atrophy)FING000004802.05e-04
11051T1 FreeSurfer DKT rh lateraloccipital volumeGCST903843572.05e-04
11052lymphocyte (absolute count, minimum, inv-norm transformed)GCST904754292.04e-04
11053T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 97)GCST903206602.04e-04
11054CD20 on IgD- CD27- B cellGCST900017542.04e-04
11055Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)FING000007512.03e-04
11056Operation code - inguinal hernia repair | OperationsUKBB000005602.03e-04
11057Atherosclerosis of native arteries of the extremities with intermittent claudication (PheCode 440.22)GCST904759912.03e-04
11058Psoriasis vulgarisFING000012242.02e-04
11059Glucose levelsGCST901327242.02e-04
11060Prostate cancerGCST904751852.02e-04
11061Basal cell carcinoma (PheCode 172.21)GCST904755822.01e-04
11062X-21353 metabolite levelGCST906167082.01e-04
11063Back pain (PheCode 760)GCST904762662.01e-04
11064MSTN/RGMA ratioGCST903155042.01e-04
11065Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T68ECGA0000682.00e-04
11066SIRT1 levelsGCST904706412.00e-04
11067HippSubfield rh volume presubiculum-bodyGCST900026972.00e-04
11068Right-hemisphere default mode network to caudate white-matter structural connectivityGCST903028451.99e-04
11069Fractured bone site(s) - Wrist | Medical conditionsUKBB000002571.99e-04
11070AmygNuclei rh volume Accessory-Basal-nucleusGCST900026601.99e-04
11071CA2/PSMG3 ratioGCST903135811.99e-04
11072GZMA levelsGCST902413231.99e-04
11073Chronic obstructive pulmonary disease in never smokersGCST900165891.99e-04
11074T1 FreeSurfer aseg Right-CaudateGCST903841621.99e-04
11075IDP dMRI ProbtrackX ISOVF slf lGCST900045461.98e-04
11076CD69/EDAR ratioGCST903138751.98e-04
11077Charcot footFING000002681.97e-04
11078LAT/LYN ratioGCST903152831.96e-04
11079Ulcerative colitisGCST904681521.96e-04
11080TFF1 levelsGCST904708351.95e-04
11081T1 FreeSurfer DK rh superiorparietal thicknessGCST903857511.93e-04
11082Takes medication for asthma?GCST904752601.93e-04
11083Graves' disease (PheCode 242.1)GCST904756441.92e-04
11084Cough (PheCode 512.8)GCST904760411.92e-04
11085Pork consumptionGCST901329991.92e-04
11086Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T447ECGA0004471.91e-04
11087Nephrotic syndromeGCST900186641.91e-04
11088eosinophil (absolute count, maximum, inv-norm transformed)GCST904752881.91e-04
11089Systolic blood pressure, combined automated + manual reading, adjusted by medication | Cardiovascular measurementUKBB000008081.90e-04
11090aparc-pial lh area postcentralGCST900031621.90e-04
11091Volume of right whole amygdalaGCST904750571.90e-04
11092T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 39)GCST903208581.90e-04
11093FXYD5/TMSB10 ratioGCST903149061.90e-04
11094Ever depressed for a whole week | Mental healthUKBB000002141.89e-04
11095SHBG levelsGCST904706221.89e-04
11096PPP1R14A levelsGCST904703021.87e-04
11097Other specified disorders of external earFING000011041.87e-04
11098Systolic blood pressure, automated reading, adjusted by medication | Cardiovascular measurementUKBB000008041.87e-04
11099Ceramide (d16:1/22:0) levelsGCST900240261.86e-04
11100CD84/SDC4 ratioGCST903139161.86e-04
11101Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T450ECGA0004501.85e-04
11102wg lh intensity-contrast cuneusGCST900037961.85e-04
11103Mosaic chromosomal alteration of the X chromosomeGCST901652871.84e-04
11104X-12510--2-aminooctanoic acid levelsGCST902437481.84e-04
11105Mouth/teeth dental problems - Bleeding gums | MouthUKBB000004851.83e-04
11106Basophil countGCST900022931.82e-04
11107NQO2 levelsGCST902426791.82e-04
11108Principal component-derived dietary pattern 10GCST901330151.81e-04
11109Cardiovascular diseases (excluding rheumatic etc)FING000002551.81e-04
11110T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 36)GCST903205991.80e-04
11111Ulcerative enterocolitisFING000013911.80e-04
11112PLA2G2A levelsGCST904702471.80e-04
11113NFATC3 levelsGCST904700341.79e-04
11114EIF4G1/FOXO1 ratioGCST903146341.79e-04
11115Self-reported risk-taking behaviourGCST0068101.79e-04
11116JAM2/TNFRSF19 ratioGCST903152411.78e-04
11117Usual side of head for mobile phone use - Equally left and right | Electronic device useUKBB000008881.78e-04
11118Cysteine-glutathione disulfide levelsGCST901997841.78e-04
11119Handedness (confirmatory factor analysis Factor 36)GCST903093701.78e-04
11120Mean platelet volume during second trimester of pregnancyGCST903022301.78e-04
11121Mid-point of the five least active hours of the dayGCST900614341.76e-04
11122Type 1 diabetes with neurological manifestations (PheCode 250.14)GCST904756641.75e-04
11123First line medication for Crohn's diseaseFING000005441.75e-04
11124SERPINB6/TXNDC5 ratioGCST903158321.74e-04
11125Left-hemisphere salience/ventral attention network to right-hemisphere control network white-matter structural connectivityGCST903027171.74e-04
11126F-sodas liking (derived food-liking factor)GCST900948421.73e-04
11127Right-hemisphere somatomotor network to caudate white-matter structural connectivityGCST903027951.72e-04
11128Number of sexual partners in opposite-sex sexual behaviorGCST900264801.72e-04
11129Gastric cancerGCST900186291.72e-04
11130Asthma and allergyFING000001151.72e-04
11131Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T426ECGU0004261.72e-04
11132aparc-a2009s rh volume S-postcentralGCST900030651.71e-04
11133Right-hemisphere limbic network to putamen white-matter structural connectivityGCST903028291.71e-04
11134GlaucomaGCST904758691.71e-04
11135DUSP3 levelsGCST904690531.70e-04
11136BOLA2 or BOLA2B levelsGCST904684601.70e-04
11137PDGFB/SNAP29 ratioGCST903156271.70e-04
11138Length of mobile phone use | Electronic device useUKBB000004031.69e-04
11139PPP1R2/TACC3 ratioGCST903157191.69e-04
11140Radiotherapy (PheCode 196)GCST904756051.68e-04
11141IKBKG levelsGCST904695421.67e-04
11142Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T259ECGA0002591.67e-04
11143CETN2 levelsGCST904687211.67e-04
11144F-vegetarian liking (derived food-liking factor)GCST900948631.66e-04
11145Basophil percentage of white cellsGCST0046311.65e-04
11146Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T270ECGU0002701.65e-04
11147Dissociative [conversion] disordersFING000004681.65e-04
11148T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 76)GCST903208951.65e-04
11149CHMP1A levelsGCST906190021.65e-04
11150DNAJA2/SCAMP3 ratioGCST903145071.64e-04
11151Vitamin B12 deficiency anaemiaFING000014411.64e-04
11152Respiratory disease (confirmatory factor analysis Factor 11)GCST903093451.64e-04
11153KLRB1 levelsGCST904697091.64e-04
11154Radial styloid tenosynovitis [de Quervain]FING000012371.64e-04
11155Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T269ECGU0002691.63e-04
11156Treatment/medication code - atenolol | MedicationsUKBB000008421.63e-04
11157APCS levelsGCST904284631.62e-04
11158IL6 expression at 6 weeks in whole blood upon Bbmix moi30 stimulation in Lyme borreliosisGCST902757891.62e-04
11159Patient classification on admission (recoded) - Day case | Summary AdministrationUKBB000006361.62e-04
11160Depression medicationsFING000003991.61e-04
11161EBAG9/EDAR ratioGCST903145631.61e-04
11162Prescriptions - lipase inhibitor|obesityUKBB000006881.61e-04
11163Prescriptions - orlistat | lipase inhibitor,obesityUKBB000006951.61e-04
11164EDAR/PSRC1 ratioGCST903145841.60e-04
11165IDP dMRI ProbtrackX OD slf rGCST900044721.60e-04
11166GET3 levelsGCST904693241.60e-04
11167Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T435ECGA0004351.59e-04
11168IDP dMRI TBSS L1 Uncinate fasciculus LGCST900041201.59e-04
11169Hypothyroidism, drug reimbursementFING000006551.57e-04
11170Right-hemisphere dorsal attention network to amygdala white-matter structural connectivityGCST903028111.57e-04
11171Otitis externaFING000011281.56e-04
11172Type 2 diabetesGCST0101181.55e-04
11173Volume of left anterior amygdaloid areaGCST904749371.54e-04
11174Urine methylsuccinoylcarnitine levels in chronic kidney diseaseGCST902655091.54e-04
11175Ulcerative colitisGCST904760671.53e-04
11176Certain disorders involving the immune mechanismFING000002641.52e-04
11177Hypertension (confirmatory factor analysis Factor 12)GCST903093461.52e-04
11178Pilonidal cystFING000011671.51e-04
11179Antihypertensive medication - note that there are other indicationsFING000000971.51e-04
11180Pulse pressure (BMI unadjusted)GCST903351661.51e-04
11181Basophil countGCST900187261.50e-04
11182Intended management of patient (recoded) - No overnight hospital stay | Summary AdministrationUKBB000003661.49e-04
11183SCRG1 levelsGCST904705541.49e-04
11184CEP43/PLXNB3 ratioGCST903140201.49e-04
11185BA-exvivo rh area BA45GCST900032291.48e-04
11186F-carbohydrate liking (derived food-liking factor)GCST900947251.48e-04
11187Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T50ECGU0000501.48e-04
11188DARS1/EIF4B ratioGCST903144031.48e-04
11189Medication use (glucocorticoids)GCST900187801.48e-04
11190DHX58 levelsGCST906182381.48e-04
11191NPDC1 levelsGCST904700691.47e-04
11192ADH4/CA5A ratioGCST903131891.47e-04
11193DKK1/VEGFA ratioGCST903144831.47e-04
11194AsthmaGCST900143251.47e-04
11195COMMD1 levelsGCST904688251.46e-04
11196Acute appendicitis, no complicationsFING000000181.46e-04
11197IDP dMRI ProbtrackX ISOVF unc lGCST900045501.46e-04
11198aparc-Desikan rh volume precuneusGCST900028251.46e-04
11199High blood pressure / hypertensionGCST904752141.46e-04
11200PIBF1 levelsGCST904702311.45e-04
11201Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T99ECGA0000991.45e-04
11202Cardiac arrhythmiasFING000002481.45e-04
11203Anomalies of dental arch relationship, including avohilmoFING000000911.45e-04
11204Coeliac diseaseFING000003121.44e-04
11205IDP dMRI ProbtrackX MD fmiGCST900042301.44e-04
11206Diseases of white blood cells (PheCode 288)GCST904758121.44e-04
11207Blood cell traits latent factor 3 (white cell)GCST905592451.44e-04
11208Psoriasis (PheCode 696.4)GCST904761871.43e-04
11209CDH1/CST3 ratioGCST903139461.43e-04
11210Body mass index (BMI, minimum, inv-normal transformed)GCST904751591.42e-04
11211CataractsGCST900185941.42e-04
11212AGT levelsGCST904682571.41e-04
11213IDP dMRI ProbtrackX L2 ifo rGCST900042861.41e-04
11214Atopic dermatitisGCST900271611.41e-04
11215T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 86)GCST903209051.40e-04
11216IDP dMRI TBSS L1 Body of corpus callosumGCST900040781.39e-04
11217Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T441ECGA0004411.39e-04
11218CD5/CD6 ratioGCST903138601.38e-04
11219GKN1 levelsGCST904693531.37e-04
11220Plasma propionylcarnitine (C3) levels in chronic kidney diseaseGCST902658761.37e-04
11221ESR1 levelsGCST904691551.37e-04
11222IDP dMRI ProbtrackX L1 unc lGCST900042711.36e-04
11223ITGAL levelsGCST904696371.36e-04
11224IL15 levelsGCST904695561.35e-04
11225Melanomas of skin, dx or hx (PheCode 172.1)GCST904755771.35e-04
11226DBI/MESD ratioGCST903144091.35e-04
11227rfMRI connectivity (ICA100 edge 1011)GCST900058641.34e-04
11228Cardiorespiratory fitness (vo2 max)GCST900933161.34e-04
11229Overweight, obesity and other hyperalimentation (PheCode 278)GCST904757591.34e-04
11230Senile cataractFING000012901.33e-04
11231lymphocyte (absolute count, mean, inv-norm transformed)GCST904754261.33e-04
11232VitiligoFING000014431.33e-04
11233Thyrotoxicosis with or without goiter (PheCode 242)GCST904756431.33e-04
11234GlaucomaGCST904753831.33e-04
11235CD3 on Terminally Differentiated CD4+ T cellGCST900018441.33e-04
11236Left ventricular outflow tract obstruction (LVOTO), broad definitionFING000007171.32e-04
11237DTI autoptx MD str r tractGCST903852441.32e-04
11238Vertical cup-disc ratioGCST0040751.31e-04
11239Soft cheese likingGCST900948431.31e-04
11240Asthma/COPD (KELA code 203)FING000001211.31e-04
11241Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T449ECGA0004491.30e-04
11242Length of working week for main job | EmploymentUKBB000004051.30e-04
11243Duration of vigorous activity | Physical activityUKBB000001991.29e-04
11244Right-hemisphere limbic network to caudate white-matter structural connectivityGCST903028281.29e-04
11245Degenerative skin conditions and other dermatoses (PheCode 702)GCST904762021.28e-04
11246COPDFING000003501.28e-04
11247Never eat wheat vs no wheat restrictions (UKB data field 6144)GCST901329321.28e-04
11248Sicca syndrome [Sjögren]FING000013041.27e-04
11249Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T442ECGA0004421.27e-04
11250IFNG levelsGCST904695151.27e-04
11251ADM levelsGCST900119961.26e-04
11252CA6/DNER ratioGCST903135941.26e-04
11253LIPF levelsGCST904697801.25e-04
11254Ulcerative colitis (strict definition, require KELA, min 2 HDR)FING000013881.25e-04
11255Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T430ECGA0004301.25e-04
11256IDP dMRI TBSS L3 Posterior thalamic radiation LGCST900042001.25e-04
11257T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 65)GCST903208841.25e-04
11258ARHGAP30 levelsGCST904683541.23e-04
11259CDC27 levelsGCST904686641.23e-04
11260Ever sought or received professional help for mental distress | Mental distressUKBB000002221.23e-04
11261Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T42ECGU0000421.23e-04
11262hematocrit (maximum, inv-norm transformed)GCST904753381.23e-04
11263Cerebrovascular disease (PheCode 433)GCST904759851.22e-04
11264Waist circumferenceGCST902786481.22e-04
11265VSTM2L levelsGCST904710571.21e-04
11266Disorders of vestibular function (Vertigo)FING000004641.21e-04
11267Takes medication for Thyroid problems?GCST904752771.20e-04
11268ACE2/MME ratioGCST903131541.20e-04
11269SNAP25 levelsGCST904220831.19e-04
11270Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T432ECGU0004321.19e-04
11271Non-allergic asthma (mode) (more control exclusions)FING000008691.19e-04
11272SERPINB1/SERPINB6 ratioGCST903158261.19e-04
11273IDP dMRI ProbtrackX L2 fmiGCST900042841.19e-04
11274Diseases of oesophagus, stomach and duodenumFING000004281.18e-04
11275Medication use (drugs affecting bone structure and mineralization)GCST900187731.18e-04
11276ELOA/POLR2F ratioGCST903146431.18e-04
11277AsthmaGCST904681121.17e-04
11278CD1C levelsGCST904686041.17e-04
11279GFRA1 levelsGCST904693281.16e-04
11280T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 16)GCST903205791.16e-04
11281DTI autoptx MD fma tractGCST903852301.15e-04
11282CD27 levelsGCST904686151.15e-04
11283CD2AP levelsGCST904686171.15e-04
11284Other and unspecified tonsillitisFING000009541.14e-04
11285Tibiofemoral angleGCST902702631.14e-04
11286KITLG levelsGCST902748331.14e-04
11287Excessive, frequent and irregular menstruationFING000005241.14e-04
11288CDSN/WFDC12 ratioGCST903139991.13e-04
11289Left-hemisphere limbic network to right-hemisphere dorsal attention network white-matter structural connectivityGCST903027311.13e-04
11290T1 FreeSurfer a2009s lh G cuneus areaGCST903846781.13e-04
11291Skin cancerGCST904751891.13e-04
11292Other anxiety disordersFING000009601.13e-04
11293T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 79)GCST903208981.13e-04
11294pro-brain natriuretic peptide (proBNP, mean, inv-norm transformed)GCST904763121.13e-04
11295SULT2A1 levelsGCST904707821.13e-04
11296Normal-pressure hydrocephalusFING000008911.12e-04
11297Systolic blood pressure, automated reading, adjusted by medication | Cardiovascular measurementUKBB000008051.12e-04
11298BCR/ITGB1BP2 ratioGCST903134941.12e-04
11299FUT8/SPARC ratioGCST903148931.12e-04
11300Pulse pressure (BMI adjusted)GCST903351671.12e-04
11301MAVS/ZBTB16 ratioGCST903154011.11e-04
11302eosinophil (absolute count, mean, inv-norm transformed)GCST904752911.11e-04
11303T1 FreeSurfer DKT rh lingual areaGCST903842971.10e-04
11304GCHFR levelsGCST904693171.10e-04
11305HippSubfield rh volume CA4-headGCST900027041.10e-04
11306Rheumatoid arthritis and other inflammatory (PheCode 714)GCST904762281.10e-04
11307METAP1D/VASH1 ratioGCST903154291.09e-04
11308Psoriasis and related disorder (PheCode 696)GCST904761861.09e-04
11309Arachidoylcarnitine (C20) levelsGCST902001351.09e-04
11310TNFRSF13B/TNFRSF9 ratioGCST903159321.09e-04
11311Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T38ECGU0000381.08e-04
11312Left-hemisphere default mode network to hippocampus white-matter structural connectivityGCST903027711.08e-04
11313IDP dMRI ProbtrackX L2 ptr lGCST900042921.08e-04
11314Eye problems/disorders - None of the above | EyesightUKBB000002321.08e-04
11315APP/TMSB10 ratioGCST903133321.07e-04
11316Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T63ECGA0000631.07e-04
11317IFI30 levelsGCST904695091.07e-04
11318SERPINA6 levelsGCST904705861.06e-04
11319CDSN/LY6D ratioGCST903139971.06e-04
11320IDP dMRI ProbtrackX FA ifo rGCST900039381.06e-04
11321T1 FreeSurfer DK rh lingual areaGCST903857011.06e-04
11322KLK11 levelsGCST900120121.06e-04
11323IntelligenceGCST0062501.05e-04
11324Congenital malformations of heart and great arteriesFING000003361.05e-04
11325Physical activity (Total log acceleration 6am-8am)GCST900614121.04e-04
11326Diastolic blood pressure (MTAG)GCST904490571.03e-04
11327Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)FING000011431.03e-04
11328Other noninfective gastroenteritis and colitisFING000010771.02e-04
11329Atopic dermatitisFING000001251.02e-04
11330CCN2/VEGFC ratioGCST903137191.02e-04
11331HippSubfield rh volume Hippocampal-tailGCST900026901.02e-04
11332DNMBP levelsGCST904690231.02e-04
11333MGLL/MITD1 ratioGCST903154361.02e-04
11334Late-onset myasthenia gravisGCST900934661.01e-04
11335Volume of left lateral nucleusGCST904749701.01e-04
11336CXCL12/TIMP3 ratioGCST903143381.01e-04
11337HippSubfield rh volume molecular-layer-HP-headGCST900026991.01e-04
11338LPCAT2 levelsGCST904697879.99e-05
11339aparc-DKTatlas rh volume precuneusGCST900029169.99e-05
11340BlepharochalasisFING000002209.95e-05
11341HSPB6 levelsGCST904694909.95e-05
11342EIF4G1/FKBP5 ratioGCST903146339.94e-05
11343MAVS levelsGCST904698669.92e-05
11344Hypertensive heart and/or renal disease (PheCode 401.2)GCST904759249.89e-05
11345Mouth/teeth dental problems - None of the above | MouthUKBB000004899.83e-05
11346Infective dermatitisFING000006739.82e-05
11347RAP1A levelsGCST904704259.76e-05
11348Gastroduodenal ulcerFING000005659.72e-05
11349KLK14 levelsGCST904697009.71e-05
11350Systolic blood pressure (MTAG)GCST904490569.70e-05
11351Low back painFING000007309.69e-05
11352Non-cancer illness code, self-reported - glaucoma | Medical conditionsUKBB000005119.66e-05
11353Asthma (adult onset)GCST0077999.66e-05
11354Systolic blood pressure (UKB data field 4080)GCST904681799.65e-05
11355IDP dMRI ProbtrackX L3 unc lGCST900043259.64e-05
11356Cauliflower likingGCST900947279.60e-05
11357SERPINA7 levelsGCST904705879.55e-05
11358Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T294ECGU0002949.49e-05
11359AsthmaGCST0100429.49e-05
11360aparc-Desikan lh area postcentralGCST900030949.49e-05
11361Asthma (more control exclusions)FING000001139.48e-05
11362CD55/CHI3L1 ratioGCST903138459.44e-05
11363Seborrhoeic keratosisFING000012839.43e-05
11364EDAR levelsGCST904690689.43e-05
11365Psoriasis vulgaris (PheCode 696.41)GCST904761909.40e-05
11366PPP1R12A/SKAP2 ratioGCST903157109.38e-05
11367HYAL1 levelsGCST904694959.38e-05
11368NBN levelsGCST904700029.34e-05
11369Endometriosis of rectovaginal septum and vaginaFING000005039.33e-05
11370PLXNB2/SEMA7A ratioGCST903156929.30e-05
11371T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 14)GCST903205779.27e-05
11372Urine glucosaminate levels in chronic kidney diseaseGCST902651799.24e-05
11373Fracture of upper limb (PheCode 803)GCST904762799.24e-05
11374TNFRSF9 levelsGCST904709169.21e-05
11375Other bacterial diseasesFING000009689.12e-05
11376TBC1D23 levelsGCST904708109.08e-05
11377aparc-pial rh area parsopercularisGCST900031919.07e-05
11378ATXN2L levelsGCST904684029.04e-05
11379Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T293ECGU0002939.02e-05
11380SMOC2 levelsGCST900600599.02e-05
11381ADAMTS16 levelsGCST904682248.99e-05
11382Systolic blood pressureGCST903102948.97e-05
11383Takes medication for Skin condition (ex. Eczema, Psoriasis)?GCST904752758.97e-05
11384ANXA3/EDAR ratioGCST903132808.97e-05
11385INSL5 levelsGCST904696228.91e-05
11386Lysoalkylphosphatidylcholine (O-22:0) levelsGCST900254348.91e-05
11387EXTL1 levelsGCST904691618.86e-05
11388LAYN/PTPRN2 ratioGCST903152908.84e-05
11389Job involved shift work | Employment historyUKBB000003828.82e-05
11390Breast cancer (estrogen-receptor negative)GCST0050768.81e-05
11391Nervonoylcarnitine (C24:1) levelsGCST902001438.78e-05
11392SEMA3G levelsGCST902427468.75e-05
11393DRAXIN levelsGCST904690388.72e-05
11394CPXM2 levelsGCST904688508.64e-05
11395Operation code - coronary angioplasty (ptca) +/- stent | OperationsUKBB000005558.64e-05
11396Malignant neoplasm of lip, excluding all cancers (controls excluding all cancers)FING000007648.63e-05
11397neutrophil (fraction, maximum, inv-norm transformed)GCST904755358.62e-05
11398IL1R2/MEGF9 ratioGCST903151598.61e-05
11399Glomerular diseasesFING000005818.58e-05
11400Methods of discharge from hospital (recoded) - Discharged on clinical advice/consent | Summary AdministrationUKBB000004668.57e-05
11401Birth year infant mortality ratesGCST900950478.56e-05
11402Prescriptions - paracetamol | antipyreticUKBB000006968.56e-05
11403Prescriptions - antipyreticUKBB000006658.56e-05
11404CCL16 levelsGCST904685688.55e-05
11405Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T37ECGU0000378.54e-05
11406DDR1/SFTPD ratioGCST903144438.51e-05
11407Early-onset myasthenia gravisGCST900934658.51e-05
11408Diseases of external earFING000004248.50e-05
11409SERPINI1 levelsGCST904706028.43e-05
11410IDP dMRI ProbtrackX FA ptr rGCST900039458.42e-05
11411Diastolic blood pressureGCST904727788.41e-05
11412CDSN/KLK8 ratioGCST903139968.40e-05
11413MAVS/SCAMP3 ratioGCST903153968.36e-05
11414Glucose levels (UKB data field 30740)GCST904680718.33e-05
11415IDP T1 FAST ROIs L thalamusGCST900025478.31e-05
11416Non-seminoma of testis, excluding all cancers (controls excluding all cancers)FING000008748.24e-05
11417T1 FreeSurfer DK rh lateraloccipital volumeGCST903857678.19e-05
11418Prescriptions - amlodipine | calcium channel blocker,dihydropyridine,anti-hypertensiveUKBB000006608.18e-05
11419DAB2/FKBP1B ratioGCST903143628.16e-05
11420Annual healthcare costGCST902926048.13e-05
11421aparc-DKTatlas lh volume precuneusGCST900028858.11e-05
11422Chronic lower respiratory diseasesFING000002908.09e-05
11423eosinophil (absolute count, minimum, inv-norm transformed)GCST904752947.97e-05
11424PM: initial answer - Orange circle| Prospective memoryUKBB000006527.90e-05
11425ICD10 O14: Pre-eclampsiaGCST904542337.89e-05
11426HealthspanGCST0074067.88e-05
11427Prescriptions - tramadol | opioid analgesic,selective serotonin re-uptake inhibitor,norepinephrine re-uptake inhibitorUKBB000007067.82e-05
11428Prescriptions - opioid analgesic|selective serotonin re-uptake inhibitor|norepinephrine re-uptake inhibitorUKBB000006947.82e-05
11429Systolic blood pressure (BMI unadjusted)GCST903351627.81e-05
11430IDP T1 FAST ROIs L cerebellum crus IGCST900025697.80e-05
11431STX6 levelsGCST904707747.80e-05
11432IRAK1/SPRY2 ratioGCST903151967.75e-05
11433T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 6)GCST903208257.74e-05
11434HippSubfield rh volume GC-ML-DG-headGCST900027017.73e-05
11435Chronic iridocyclitisFING000002877.69e-05
11436SPOCK1 levelsGCST904707307.69e-05
11437CCL11/CCL2 ratioGCST903136727.68e-05
11438MED18/ZBTB16 ratioGCST903154167.63e-05
11439BA-exvivo lh area BA2GCST900032087.59e-05
11440AAMDC levelsGCST904681867.59e-05
11441FOXO1/NUB1 ratioGCST903148747.57e-05
11442CCDC50 levelsGCST904685617.55e-05
11443aseg rh intensity PallidumGCST900037857.54e-05
11444Biological Mother: High blood pressureGCST904754907.47e-05
11445BTN2A1/SPINT2 ratioGCST903135507.46e-05
11446CD83/IL12A_IL12B ratioGCST903139057.45e-05
11447Takes medication for high blood pressure?GCST904752167.44e-05
11448aparc-DKTatlas lh area postcentralGCST900032547.42e-05
11449Lysoalkylphosphatidylcholine (O-24:0) levelsGCST900241977.40e-05
11450Separation of retinal layers (serosa)FING000012927.38e-05
11451Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T431ECGA0004317.37e-05
11452AGRN levelsGCST904682557.33e-05
11453Childhood body mass indexGCST900024097.28e-05
11454Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor - Hayfever, allergic rhinitis or eczema | Medical conditionsUKBB000001007.25e-05
11455UPB1 levelsGCST904710137.20e-05
11456HypertensionGCST900860927.19e-05
11457Benign neoplasm: RectumFING000001967.13e-05
11458SRPK2/VASH1 ratioGCST903158867.12e-05
11459Non-cancer illness code, self-reported - asthma | Medical conditionsUKBB000005067.12e-05
11460POMC levelsGCST904702846.98e-05
11461CCL20 levelsGCST904685726.98e-05
11462REN levelsGCST904704546.98e-05
11463aparc-DKTatlas rh area parsopercularisGCST900032816.96e-05
11464MZB1 levelsGCST904699876.96e-05
11465SPINK1 levelsGCST904707216.96e-05
11466Rubneribacter sp002159915 abundance in stoolGCST900325416.96e-05
11467IDP dMRI ProbtrackX L1 cgh lGCST900042526.95e-05
11468Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T436ECGA0004366.95e-05
11469MPIG6B/PDGFB ratioGCST903154826.94e-05
11470TNFSF13B levelsGCST904709206.93e-05
11471GNLY/GZMA ratioGCST903149496.93e-05
11472Ground coffee consumptionGCST901329766.88e-05
11473DBNL/EDAR ratioGCST903144166.82e-05
11474Esophagitis, GERD and related diseases | digestiveUKBB000002086.80e-05
11475F-coffee/alcohol liking (derived food-liking factor)GCST900947376.79e-05
11476Number of days/week of vigorous physical activity 10+ minutes | Physical activityUKBB000005346.78e-05
11477SNAP23/SNAP29 ratioGCST903158556.76e-05
11478MEPE/SOST ratioGCST903154206.72e-05
11479CLEC4C levelsGCST904687726.68e-05
11480CA9/CBLIF ratioGCST903135956.64e-05
11481IDP dMRI ProbtrackX L3 ptr lGCST900043196.63e-05
11482Duration walking for pleasure | Physical activityUKBB000002036.54e-05
11483PLXNA4/SPRY2 ratioGCST903156876.54e-05
11484Oral glucose tolerance test-2hGCST905664236.51e-05
11485Glycosyl ceramide (d18:2/24:1, d18:1/24:2) levelsGCST902001186.46e-05
11486Lung cancerGCST900186556.44e-05
11487Physical activityGCST900933236.43e-05
11488Skin colour | Sun exposureUKBB000007736.40e-05
11489Biological Father: Coronary Artery / Coronary Heart DiseaseGCST904752416.39e-05
11490F-strong alcohol liking (derived food-liking factor)GCST900948506.36e-05
11491CNST/DOK2 ratioGCST903141576.34e-05
11492Secondary hypothyroidism (PheCode 244.1)GCST904756496.27e-05
11493Job involves mainly walking or standing | EmploymentUKBB000003846.26e-05
11494Alanine levelsGCST904970856.26e-05
11495Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T36ECGU0000366.26e-05
11496REN levelsGCST900120386.26e-05
11497CDSN/NECTIN4 ratioGCST903139986.25e-05
11498Type 1 diabetesGCST900137916.20e-05
11499CASP8/PPP3R1 ratioGCST903136546.17e-05
11500IDP T1 FAST ROIs R parietal operc cortexGCST900025366.15e-05
11501WASF1 levelsGCST904710676.15e-05
11502SERPINC1 levelsGCST904705946.08e-05
11503Childhood asthma (age<16) (more control exclusions)FING000002705.96e-05
11504Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor - None of the above | Medical conditionsUKBB000001015.95e-05
11505Takes medication for skin cancer?GCST904751905.95e-05
11506CRTAM levelsGCST904688715.95e-05
11507KLK8/NECTIN4 ratioGCST903152585.85e-05
11508DNMBP/PTPN1 ratioGCST903145175.78e-05
11509FCRL5/TNFRSF13B ratioGCST903148055.78e-05
11510DTI autoptx L1 ifo r tractGCST903851525.76e-05
11511Colon cancer/rectal cancerGCST904751705.74e-05
11512FGF21 levelsGCST902747885.73e-05
11513Noninfectious disorders of lymphatic channels (PheCode 450)GCST904760025.73e-05
11514Basal cell carcinomaGCST900134105.71e-05
11515GNLY levelsGCST904693725.68e-05
11516Heart failureGCST0095415.65e-05
11517T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 26)GCST903205895.54e-05
11518Left-hemisphere salience/ventral attention network to right-hemisphere default mode network white-matter structural connectivityGCST903027185.52e-05
11519Other alveolar and parietoalveolar pneumonopathy (PheCode 504)GCST904760335.50e-05
11520F11R/PARK7 ratioGCST903147235.50e-05
11521IDP dMRI ProbtrackX MD unc lGCST900042445.49e-05
11522Other diseases of intestine | Other diseases of intestinesUKBB000006055.49e-05
11523Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T284ECGU0002845.48e-05
11524CKMT1A or CKMT1B levelsGCST904687605.48e-05
11525Primary angle-closure glaucomaFING000012105.47e-05
11526Principal component-derived dietary pattern 9GCST901330145.45e-05
11527AZU1/RNASE3 ratioGCST903134285.43e-05
11528METAP2/RILP ratioGCST903154335.42e-05
11529GZMA levelsGCST904694235.42e-05
11530Systolic blood pressure (BMI adjusted)GCST903351635.41e-05
11531FCRL6 levelsGCST904692095.36e-05
11532CD74/DLL1 ratioGCST903138915.36e-05
11533Glomerular disorders in diseases classified elsewhereFING000005825.35e-05
11534aparc-pial lh area precuneusGCST900031655.34e-05
11535BCL2L11 levelsGCST904684305.31e-05
11536Lung cancer in never smokersGCST902774345.31e-05
11537Hypothyroidism (PheCode 244)GCST904756475.30e-05
11538Monocyte percentage of white cellsGCST900023945.30e-05
11539Systemic connective tissue disordersFING000013505.24e-05
11540ORM1 levelsGCST904701295.19e-05
11541FOLH1 levelsGCST902412725.18e-05
11542Hypothyroidism | endocrine/metabolicUKBB000003355.16e-05
11543Lower back pain or/and sciaticaFING000007315.14e-05
11544Crohn's disease of small intestineFING000003695.14e-05
11545SELPLG levelsGCST904705685.13e-05
11546CC2D1A/STAMBP ratioGCST903136645.12e-05
11547HRG levelsGCST904694765.11e-05
11548Tryptophan betaine levelsGCST901998195.09e-05
11549Total lipid levels in IDLGCST901326335.09e-05
11550CRADD/EDAR ratioGCST903142355.09e-05
11551T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 116)GCST903209355.09e-05
11552CD300LF levelsGCST904686225.07e-05
11553Prescriptions - thiazide diuretic|diureticUKBB000007045.04e-05
11554GNE levelsGCST904693705.01e-05
11555DOK2 levelsGCST904690294.95e-05
11556KIR2DL2 levelsGCST904696844.94e-05
11557FGF2 levelsGCST904692244.92e-05
11558POSTN levelsGCST904702884.91e-05
11559SCGN levelsGCST904705444.90e-05
11560Kela-code for severe mental illnessFING000007074.90e-05
11561CRYGD levelsGCST904688764.89e-05
11562X-24406 metabolite levelGCST906167894.89e-05
11563FLT4/KDR ratioGCST903148614.87e-05
11564Moderate to vigorous physical activity durationGCST900614224.87e-05
11565VCAM1 levelsGCST902433174.87e-05
11566AARSD1/PIK3AP1 ratioGCST903131294.84e-05
11567aparc-DKTatlas rh volume precentralGCST900029154.83e-05
11568aparc-a2009s lh area S-orbital-H-ShapedGCST900033604.81e-05
11569Anaphylactic shock due to adverse effect of correct drug or medication properly administeredFING000000844.80e-05
11570Myasthenia gravisGCST900930614.79e-05
11571HGF/MMP9 ratioGCST903150564.78e-05
11572Restless legs syndrome (PheCode 327.71)GCST904758294.78e-05
11573Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T221ECGA0002214.76e-05
11574Skin elastin (cheek, R5)GCST905027874.72e-05
11575Mean arterial pressure, automated reading, adjusted by medication | Cardiovascular measurementUKBB000004354.71e-05
11576Noninfective enteritis and colitisFING000008814.70e-05
11577Nasal polyp | Other diseases of upper respiratory tractUKBB000004934.64e-05
11578Obesity (PheCode 278.1)GCST904757624.61e-05
11579CA2/UBAC1 ratioGCST903135834.59e-05
11580OLR1 levelsGCST900120204.59e-05
11581Encounter for long-term (current) use of anticoagulants (PheCode 286.2)GCST904757994.58e-05
11582ADIPOQ levelsGCST902930864.57e-05
11583aseg rh intensity Thalamus-ProperGCST900037824.57e-05
11584Atrial septal defectFING000001284.56e-05
11585Ever highly irritable/argumentative for 2 days | Mental healthUKBB000002194.52e-05
11586HLA-E levelsGCST904694594.49e-05
11587Inflammatory bowel diseaseGCST904321824.48e-05
11588C1QL2 levelsGCST904684874.44e-05
11589MYOC/NOTCH3 ratioGCST903155074.42e-05
11590Membranous nephropathyGCST0100064.42e-05
11591PRKG1 levelsGCST904703304.41e-05
11592S100A16 levelsGCST904705164.41e-05
11593EDAR/SPARC ratioGCST903145884.41e-05
11594Dermatitis due to ingested foodFING000004034.38e-05
11595Intra-ocular pressure, corneal-compensated (left) | Intraocular pressureUKBB000003744.36e-05
11596Plasma taurocholenate sulfate* levels in chronic kidney diseaseGCST902660404.35e-05
11597HBEGF/LAT2 ratioGCST903150324.34e-05
11598Primary biliary cholangitisGCST900614404.32e-05
11599aseg lh intensity Cerebellum-CortexGCST900037674.32e-05
11600Mean arterial pressure, combined automated + manual reading, adjusted by medication | Cardiovascular measurementUKBB000004404.32e-05
11601Diastolic blood pressureGCST904727794.31e-05
11602AsthmaGCST900185754.30e-05
11603Essential hypertension | circulatory systemUKBB000002094.25e-05
11604Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)FING000007494.23e-05
11605Preeclampsia or other maternal hypertension (maternal genotype effect)GCST902699044.21e-05
11606TSHB levelsGCST904709744.18e-05
11607PDCD1/TNFRSF8 ratioGCST903156104.14e-05
11608FCRL5/LY96 ratioGCST903148034.13e-05
11609Birth weight | Early life factorsUKBB000000954.13e-05
11610ABL1/DNMBP ratioGCST903131494.12e-05
11611Poisoning by antibiotics | injuries & poisoningsUKBB000006534.11e-05
11612DermatitisFING000004014.10e-05
11613MYBPC1 levelsGCST904699694.08e-05
11614Hypertension | circulatory systemUKBB000003344.08e-05
11615aparc-Desikan lh thickness cuneusGCST900034494.05e-05
11616Intrahepatic Cholestasis of Pregnancy (ICP)  (more control exclusions)FING000006924.04e-05
11617IDP T1 FAST ROIs L cerebellum XGCST900025874.01e-05
11618VSIG4 levelsGCST904710523.99e-05
11619GDNF levelsGCST904693233.98e-05
11620Mean arterial pressure, combined automated + manual reading, adjusted by medication | Cardiovascular measurementUKBB000004393.98e-05
11621Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T41ECGU0000413.98e-05
11622NID1/TIMP3 ratioGCST903155433.96e-05
11623Age hay fever, rhinitis or eczema diagnosed | Medical conditionsUKBB000000153.96e-05
11624CTSZ levelsGCST904689183.96e-05
11625Mosaic chromosomal alteration of the Y chromosomeGCST901652893.95e-05
11626EDAR/ENO2 ratioGCST903145743.94e-05
11627OCLN levelsGCST904701143.93e-05
11628Allergy/adverse effect of penicillin | injuries & poisoningsUKBB000000283.93e-05
11629Mean arterial pressure, combined automated + manual reading | Cardiovascular measurementUKBB000004373.91e-05
11630EDAR/PRDX5 ratioGCST903145833.88e-05
11631IDP dMRI ProbtrackX FA ptr lGCST900039443.88e-05
11632PDGFA/PLA2G4A ratioGCST903156153.87e-05
11633IDP dMRI TBSS L1 Cingulum hippocampus RGCST900041113.83e-05
11634Melanocytic naevi of trunkFING000008003.82e-05
11635FOXO1/IRAK4 ratioGCST903148703.80e-05
11636Ceramide (d17:1/24:0) levelsGCST900240333.79e-05
11637CHAC2 levelsGCST904687363.77e-05
11638CDH15 levelsGCST904686683.77e-05
11639SKAP2 levelsGCST904706463.76e-05
11640Allergic disease (asthma, hay fever or eczema)GCST0050383.74e-05
11641Plasma X-24544 levels in chronic kidney diseaseGCST902667573.74e-05
11642FASLG levelsGCST904691913.72e-05
11643Monocyte percentage | Blood countUKBB000004803.71e-05
11644Lateral epicondylitisFING000007153.70e-05
11645Lymphocyte countGCST0046273.68e-05
11646IL15/KLRD1 ratioGCST903151493.68e-05
11647Volume of right cortico-amygdaloid transition areaGCST904749133.66e-05
11648EFNA4/TNFRSF10B ratioGCST903146053.63e-05
11649IridocyclitisFING000006963.63e-05
11650Treatment/medication code - levothyroxine sodium | MedicationsUKBB000008493.63e-05
11651FCRL2 levelsGCST904692063.63e-05
11652Diastolic blood pressureGCST903102953.59e-05
11653FOLR2/HAVCR2 ratioGCST903148653.57e-05
11654INPP1/NT5C3A ratioGCST903151773.57e-05
11655Right-hemisphere somatomotor network to amygdala white-matter structural connectivityGCST903027993.56e-05
11656Mean platelet volume during third trimester of pregnancyGCST903022313.54e-05
11657BST2/MME ratioGCST903135393.51e-05
11658Diastolic blood pressure (BMI adjusted)GCST903351653.49e-05
11659Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T43ECGU0000433.48e-05
11660IDP dMRI TBSS ISOVF Posterior thalamic radiation RGCST900045053.47e-05
11661Varicose veins (PheCode 454)GCST904760123.47e-05
11662aparc-Desikan lh volume precuneusGCST900027923.47e-05
11663Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T65ECGA0000653.46e-05
11664DTI TBSS L2 Medial lemniscus LGCST903844853.46e-05
11665Prescriptions - calcium channel blocker|dihydropyridine|anti-hypertensiveUKBB000006733.44e-05
11666aparc-Desikan rh area parsopercularisGCST900031243.44e-05
11667Non-cancer illness code, self-reported - hayfever/allergic rhinitis | Medical conditionsUKBB000005133.43e-05
11668CD160/NCR1 ratioGCST903137323.38e-05
11669Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T441ECGU0004413.37e-05
11670Mean arterial pressure, automated reading | Cardiovascular measurementUKBB000004333.37e-05
11671Milk chocolate likingGCST900948013.36e-05
11672BECN1 levelsGCST904684383.36e-05
11673Moderate-to-vigorous intensity physical activity during leisure timeGCST901043413.35e-05
11674GZMB/IL15 ratioGCST903150153.31e-05
11675PFKM levelsGCST906188023.29e-05
11676Hypothyroidism NOS (PheCode 244.4)GCST904756533.29e-05
11677MUC2 levelsGCST904699653.26e-05
11678Mean arterial pressure, combined automated + manual reading | Cardiovascular measurementUKBB000004383.23e-05
11679FHIT/GLOD4 ratioGCST903148173.22e-05
11680Olsenella C abundance in stoolGCST900324933.22e-05
11681Capers likingGCST900947243.22e-05
11682SPON2 levelsGCST904707323.22e-05
11683Systolic blood pressureGCST903016953.20e-05
11684RHOC/TBCC ratioGCST903157753.17e-05
11685neutrophil (absolute count, maximum, inv-norm transformed)GCST904755263.17e-05
11686KITLG levelsGCST900120233.16e-05
11687IL12RB1 levelsGCST904695503.15e-05
11688aparc-a2009s rh area G-precuneusGCST900034003.14e-05
11689CLEC4G/LGALS4 ratioGCST903141203.13e-05
11690Ceramide (d16:1/24:0) levelsGCST900240273.12e-05
11691Diseases of middle ear and mastoidFING000004273.12e-05
11692Obesity, other/unspecifiedFING000008983.11e-05
11693Left-hemisphere visual network to right-hemisphere limbic network white-matter structural connectivityGCST903026593.11e-05
11694CCL5/TACC3 ratioGCST903137073.09e-05
11695Myocardial fractal dimension (slice 8)GCST900002943.08e-05
11696CCL4 levelsGCST904685833.06e-05
11697CCL2 levelsGCST904685813.05e-05
11698CNST/ITGB1BP2 ratioGCST903141583.02e-05
11699ICAM3 levelsGCST904695003.01e-05
11700Non-cancer illness code, self-reported - hypothyroidism/myxoedema | Medical conditionsUKBB000005183.01e-05
11701Otitis externa, unspecifiedFING000011293.00e-05
11702ITGB1BP2/TIA1 ratioGCST903152222.99e-05
11703Left-hemisphere limbic network to right-hemisphere limbic network white-matter structural connectivityGCST903027332.98e-05
11704Handedness (chirality/laterality) - Right-handed | Early life factorsUKBB000003032.97e-05
11705DTI TBSS L2 Cingulum hippocampus LGCST903845132.96e-05
11706X-03056--N-[3- 2-Oxopyrrolidin-1-yl propyl]acetamide levelsGCST902436192.95e-05
11707ObesityFING000008952.94e-05
11708Maximum heart rate during fitness test | ECG during exerciseUKBB000004312.93e-05
11709Age-related macular degenerationGCST900861112.91e-05
11710ASS1 levelsGCST904683802.87e-05
11711SCG2 levelsGCST904705382.87e-05
11712Leisure/social activities - Other group activity | Social supportUKBB000004002.86e-05
11713Histidine levelsGCST900928302.86e-05
11714Monocyte percentage (UKB data field 30190)GCST904680912.85e-05
11715SKAP1 levelsGCST904706452.81e-05
11716Macular degeneration, wet (PheCode 362.22)GCST904758522.80e-05
11717Viral and other specified intestinal infectionsFING000014322.80e-05
11718X-11550 levelsGCST902436482.77e-05
11719FADD/NFATC1 ratioGCST903147712.75e-05
11720Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T35ECGU0000352.73e-05
11721COL1A1 levelsGCST902407442.73e-05
11722Skin cancer | neoplasmsUKBB000007722.73e-05
11723ATP5IF1/HSPA1A ratioGCST903133882.73e-05
11724aparc-a2009s rh volume S-parieto-occipitalGCST900030632.70e-05
11725KIR3DL1 levelsGCST904696872.69e-05
11726FYB1/PDGFB ratioGCST903149122.68e-05
11727REG4 levelsGCST904704512.68e-05
11728IDP dMRI ProbtrackX FA fmiGCST900039362.67e-05
11729NAP1L4 levelsGCST904699982.66e-05
11730N-acetylphenylalanine levels in chronic kidney diseaseGCST902575372.66e-05
11731Lymphoid leukaemia (controls excluding all cancers)FING000007412.65e-05
11732Disorder of skin and subcutaneous tissue NO (PheCode 689)GCST904761692.63e-05
11733Hypothyroidism NOS | endocrine/metabolicUKBB000003362.58e-05
11734Excessive hairinessGCST0060952.58e-05
11735CRKL/DBNL ratioGCST903142632.58e-05
11736aparc-a2009s lh thickness G-precuneusGCST900036322.57e-05
11737DBI/EDAR ratioGCST903144082.57e-05
11738THBD levelsGCST900120482.54e-05
11739BA-exvivo lh volume BA2GCST900028362.51e-05
11740CD160/KLRB1 ratioGCST903137312.50e-05
11741CAPS levelsGCST904685392.48e-05
11742Peripheral or central vertigo (PheCode 386.2)GCST904759072.48e-05
11743Number of operations, self-reported | OperationsUKBB000005392.46e-05
11744Pain in joint (PheCode 745)GCST904762622.46e-05
11745Volume of right accessory basal nucleusGCST904750092.44e-05
11746T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 81)GCST903209002.42e-05
11747FABP1 levelsGCST904691732.42e-05
11748Corneal dystrophy (PheCode 364.5)GCST904758642.40e-05
11749Other hypothyroidism | Disorders of thyroid glandUKBB000006112.40e-05
11750LY6D/WFDC12 ratioGCST903153462.39e-05
11751Non-cancer illness code, self-reported - hiatus hernia | Medical conditionsUKBB000005152.38e-05
11752F-cake/biscuits liking (derived food-liking factor)GCST900947222.38e-05
11753Medication for pain relief, constipation, heartburn - Omeprazole (e.g. Zanprol) | MedicationUKBB000004582.37e-05
11754Hypothyroidism, strict autoimmuneFING000006562.37e-05
11755Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T60ECGA0000602.36e-05
11756PGR levelsGCST904702232.34e-05
11757PATE4 levelsGCST902424052.34e-05
11758C9 levelsGCST904685052.34e-05
11759Varicose veins of lower extremity, symptomtic (PheCode 454.11)GCST904760142.34e-05
11760Methods of admission to hospital (recoded) - Elective admission: Waiting List | Summary AdministrationUKBB000004632.33e-05
11761Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T34ECGU0000342.32e-05
11762Optic cup areaGCST0041372.31e-05
11763Other disorders of eyelidFING000010262.30e-05
11764CCL8 levelsGCST904685862.29e-05
11765FUT3 levelsGCST902412162.29e-05
11766Glycerate levelsGCST902002902.29e-05
117671-stearoyl-GPE (18:0) levelsGCST901997722.28e-05
11768IDP dMRI TBSS OD Anterior limb of internal capsule LGCST900044192.28e-05
11769Operative procedures - Unspecified diagnostic endoscopic examination of colon | Summary OperationsUKBB000005912.27e-05
11770aseg lh intensity PallidumGCST900037712.26e-05
11771DAG1/GP6 ratioGCST903143752.22e-05
11772Medication use (drugs used in diabetes)GCST900187612.21e-05
11773Body-mass index, inverse-rank normalizedFING000002222.15e-05
11774Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor - Asthma | Medical conditionsUKBB000000982.14e-05
11775Leisure/social activities - Adult education class | Social supportUKBB000003982.12e-05
11776CCL18/RARRES2 ratioGCST903136902.11e-05
11777GUSB levelsGCST904694212.08e-05
11778Ulcerative colitis (strict) with PSCFING000013892.07e-05
11779Mean arterial pressure, automated reading | Cardiovascular measurementUKBB000004342.06e-05
11780TIRAP levelsGCST902430322.06e-05
11781PIK3AP1/PSMG3 ratioGCST903156512.04e-05
11782Treatment/medication code - amlodipine | MedicationsUKBB000008402.04e-05
11783IDP dMRI ProbtrackX FA unc lGCST900039502.03e-05
11784Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T46ECGU0000462.02e-05
11785Valvular heart disease excluding rheumatic feverFING000014142.02e-05
11786PPME1 levelsGCST904702982.02e-05
11787FABP4/SNCG ratioGCST903147591.97e-05
11788IDP T1 FAST ROIs R postcent gyrusGCST900024841.95e-05
11789YOD1 levelsGCST904710901.93e-05
11790DKK1/PDGFA ratioGCST903144751.93e-05
11791Mean arterial pressure (BMI adjusted)GCST903351691.90e-05
11792Left-hemisphere default mode network to right-hemisphere default mode network white-matter structural connectivityGCST903027661.89e-05
11793Diastolic blood pressureGCST903016991.89e-05
11794Iron deficiency anemia secondary to blood loss (chronic) (PheCode 280.2)GCST904757701.87e-05
11795Octadecenedioate (C18:1-DC) levelsGCST902001651.87e-05
11796Diseases of hair and hair follicles (PheCode 704)GCST904762091.87e-05
11797CIAPIN1/SPARC ratioGCST903140691.86e-05
11798Basal cell carcinoma (MTAG)GCST901374111.86e-05
11799CA2/CA3 ratioGCST903135761.86e-05
11800Erectile dysfunctionGCST0069561.86e-05
11801X-21285 levelsGCST902005761.85e-05
11802Endometriosis of pelvic peritoneumFING000005021.84e-05
11803DNER levelsGCST902747851.83e-05
11804neutrophil (fraction, mean, inv-norm transformed)GCST904755381.81e-05
11805Mean arterial pressure, automated reading, adjusted by medication | Cardiovascular measurementUKBB000004361.80e-05
11806IDP T1 FAST ROIs L cerebellum VGCST900025641.79e-05
11807Urinary tryptophan to urinary creatinine ratioGCST904517481.78e-05
11808Glaucoma (PheCode 365)GCST0083731.77e-05
11809MED18/TACC3 ratioGCST903154141.76e-05
11810aseg rh volume CaudateGCST900026381.75e-05
11811Treatment/medication code - bendroflumethiazide | MedicationsUKBB000008431.72e-05
11812Left-hemisphere default mode network to right-hemisphere control network white-matter structural connectivityGCST903027651.70e-05
11813Omega-3 fatty acids to Omega-6 fatty acids ratioGCST905020741.68e-05
11814aparc-a2009s lh volume G-precuneusGCST900029541.68e-05
11815ICD10 O20: Haemorrhage in early pregnancyGCST904542351.67e-05
11816EDAR/IRAK4 ratioGCST903145791.67e-05
11817Tyrosine levelsGCST902434251.66e-05
11818PDGFA/SNAP23 ratioGCST903156191.64e-05
11819Noninflammatory disorders of female genital tractFING000008821.63e-05
11820Multi-trait sum scoreGCST902701171.62e-05
11821RGMA/RGMB ratioGCST903157691.62e-05
11822aparc-Desikan lh thickness precuneusGCST900034691.61e-05
11823Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8 (more control exclusions)FING000006941.60e-05
11824Phosphatidylcholine acyl-alkyl C36:4 levelsGCST902400721.59e-05
11825Mouth/teeth dental problems - Dentures | MouthUKBB000004861.57e-05
11826Oily fish intake | DietUKBB000005471.57e-05
11827Vascular/heart problems diagnosed by doctor - High blood pressure | Medical conditionsUKBB000008981.55e-05
11828HippSubfield rh volume hippocampal-fissureGCST900026941.53e-05
11829RNF5 levelsGCST904704881.52e-05
11830Mean arterial pressure (BMI unadjusted)GCST903351681.51e-05
11831Acute appendicitisFING000000171.51e-05
11832IL18 levelsGCST904284111.50e-05
11833Other heart diseasesFING000010571.50e-05
11834DTI autoptx MD unc r tractGCST903852461.50e-05
11835Other malignant neoplasms of skin | Melanoma and other malignant neoplasms of skinUKBB000006131.45e-05
11836Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T67ECGA0000671.45e-05
11837CA5A/KRT18 ratioGCST903135921.44e-05
11838CCN2/SERPINB1 ratioGCST903137151.44e-05
11839GP2/LGALS4 ratioGCST903149601.43e-05
11840IDP dMRI TBSS L2 Genu of corpus callosumGCST900041251.43e-05
11841Essential hypertension (PheCode 401.1)GCST904759221.42e-05
11842Primary Raynaud’s phenomenonGCST902717141.41e-05
11843CASP3/PDGFB ratioGCST903136381.39e-05
11844IL16 levelsGCST902415961.39e-05
11845MEP1A levelsGCST904698871.39e-05
11846ATP5IF1/FXN ratioGCST903133861.39e-05
11847Frailty (Factor 6 - Disability)GCST906240521.37e-05
11848APOL1 levelsGCST904683411.37e-05
11849DYNLT1 levelsGCST904690571.36e-05
11850T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 25)GCST903205881.36e-05
11851Left-hemisphere control network to right-hemisphere default mode network white-matter structural connectivityGCST903027511.35e-05
11852IRAK1/NFATC1 ratioGCST903151941.34e-05
11853PLA2G15 levelsGCST904702451.33e-05
11854Pizza likingGCST900948101.33e-05
11855Treatment/medication code - salbutamol | MedicationsUKBB000008571.32e-05
11856Illnesses of father - None of the above (group 2) | Family historyUKBB000003461.31e-05
11857wg lh intensity-contrast lingualGCST900038041.30e-05
11858COMT levelsGCST904688281.30e-05
11859SCN4B levelsGCST904705511.30e-05
11860neutrophil (fraction, minimum, inv-norm transformed)GCST904755411.29e-05
11861GBP1 levelsGCST904693111.28e-05
11862CASP3/PDGFA ratioGCST903136371.28e-05
11863CCL3 levelsGCST904685821.28e-05
11864Left-hemisphere limbic network to putamen white-matter structural connectivityGCST903027381.24e-05
11865CDKN2D/MANF ratioGCST903139891.24e-05
11866Melanocytic naevi, other sites/unspecifiedFING000008021.21e-05
11867F2R/SPINT2 ratioGCST903147371.21e-05
11868Other acute lower respiratory infectionsFING000009211.21e-05
11869Leisure/social activities - Sports club or gym | Social supportUKBB000004021.21e-05
11870Melanoma in situ (controls excluding all cancers)FING000008031.21e-05
11871Seborrheic dermatitis (PheCode 690.1)GCST904761711.21e-05
11872Age-related macular degeneration (whether dry or wet)FING000000471.21e-05
11873Cancer within the respiratory system (PheCode 165)GCST904755711.21e-05
11874Coffee max likingGCST900947391.21e-05
11875FCRL6/KLRD1 ratioGCST903148071.20e-05
11876GLOD4/S100A4 ratioGCST903149441.19e-05
11877Lymphocyte percentage of white cellsGCST0046321.19e-05
11878Erythematosquamous dermatosis (PheCode 690)GCST904761701.19e-05
11879Basophil percentage of granulocytesGCST0046341.19e-05
11880Alkylphosphatidylcholine (O-34:1) levelsGCST900255511.18e-05
11881Principal component-derived dietary pattern 45GCST901330501.17e-05
11882aparc-DKTatlas lh area precuneusGCST900032571.16e-05
11883LILRB4 levelsGCST904697781.16e-05
11884SERPINE2 levelsGCST904705971.15e-05
11885Monocyte percentage of white cellsGCST0046091.15e-05
11886CCL18 levelsGCST904685701.14e-05
11887Volume of right anterior amygdaloid areaGCST904750031.14e-05
11888HAVCR2/TNFRSF1B ratioGCST903150301.13e-05
11889Ceramide (d17:1/22:0) levelsGCST900240321.13e-05
11890EDAR/SNAP23 ratioGCST903145871.12e-05
11891CCL22 levelsGCST904685741.12e-05
11892Inflammatory bowel disease and other gasteroenteritis and colitis (PheCode 555)GCST904760651.10e-05
11893Vascular/heart problems diagnosed by doctor - None of the above | Medical conditionsUKBB000008991.09e-05
11894T1 FreeSurfer BA rh BA4p exvivo areaGCST903855521.09e-05
11895ATP5IF1/DECR1 ratioGCST903133821.09e-05
11896Body mass indexGCST905029121.06e-05
11897TXLNA levelsGCST904709891.06e-05
11898BLVRB/CA3 ratioGCST903135231.03e-05
11899KRT5 levelsGCST904697181.03e-05
11900White blood cell count (basophil)GCST0046181.02e-05
11901EczemaGCST904681261.01e-05
11902Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T222ECGA0002221.00e-05
11903FracturesGCST0069801.00e-05
11904Milk type used - Full cream | DietUKBB000004689.99e-06
11905IDP T1 FAST ROIs R precentral gyrusGCST900024649.97e-06
11906Right-hemisphere visual network to accumbens white-matter structural connectivityGCST903027879.92e-06
11907Gastric ulcerGCST900186319.87e-06
11908PsoriasisGCST900190169.82e-06
11909Lymphocyte count (UKB data field 30120)GCST904680829.69e-06
11910Lymphocyte countGCST900259849.64e-06
11911Suppurative and unspecified otitis mediaFING000013469.55e-06
11912NTN1 levelsGCST902420479.39e-06
11913Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T223ECGA0002239.36e-06
11914Follicular lymphoma, hilmo (controls excluding all cancers)FING000005489.30e-06
11915Primary sclerosing cholangitisGCST0040309.26e-06
11916HypothyroidismGCST903193209.23e-06
11917Systolic blood pressure (standard GWA)GCST902673049.22e-06
11918IDP T1 FAST ROIs L cerebellum VIIbGCST900025759.17e-06
11919Disorders of the thyroid glandFING000004639.08e-06
11920LEG1 levelsGCST904697539.06e-06
11921IDP dMRI ProbtrackX L3 fmiGCST900043119.01e-06
11922GZMA/TNFRSF8 ratioGCST903150148.92e-06
11923Gestational age at birth (child effect)GCST902684218.88e-06
11924Alcohol likingGCST900946888.81e-06
11925Physical activity (Principal component 2)GCST900614238.73e-06
11926Neoplasm of uncertain behavior of skin (PheCode 173)GCST904755858.61e-06
11927FCRL5 levelsGCST904692088.56e-06
11928Alcohol-induced chronic pancreatitisFING000000558.56e-06
11929ITGB1BP2/MITD1 ratioGCST903152148.56e-06
11930CD302/IL12A_IL12B ratioGCST903138068.45e-06
11931Other Crohn's diseaseFING000009928.29e-06
11932IDP dMRI ProbtrackX MD ptr lGCST900042388.26e-06
11933lymphocyte (fraction, minimum, inv-norm transformed)GCST904754388.26e-06
11934Cream likingGCST900947468.23e-06
11935Tryptophan levelsGCST902434038.03e-06
11936OLR1/PLAUR ratioGCST903155847.89e-06
11937Lymphocyte countGCST900023167.87e-06
11938Other bacterial intestinal infectionsFING000009697.87e-06
11939Blood cell traits latent factor 23 (white cell)GCST905592657.84e-06
11940Diastolic blood pressure (BMI unadjusted)GCST903351647.82e-06
11941PPIE levelsGCST902422177.74e-06
11942EDAR/ITGB1BP2 ratioGCST903145807.74e-06
11943Sleep related movement disorders (PheCode 327.7)GCST904758277.73e-06
11944Diarrhoea and gastroenteritis of presumed infectious originFING000004207.64e-06
11945EDAR/SERPINB1 ratioGCST903145867.60e-06
11946Blood cell traits latent factor 16 (white cell)GCST905592587.59e-06
11947Non-cancer illness code, self-reported - hypertension | Medical conditionsUKBB000005177.58e-06
11948SLIT2 levelsGCST904706687.47e-06
11949Lymphocyte countGCST900023887.40e-06
11950Use of dietary supplements (confirmatory factor analysis Factor 13)GCST903093477.37e-06
11951DTI TBSS L2 Genu of corpus callosumGCST903844787.32e-06
11952ITGB1BP2/MED18 ratioGCST903152137.24e-06
11953GP6/SCARF1 ratioGCST903149697.18e-06
11954Blood cell traits latent factor 18 (platelet)GCST905592607.16e-06
11955HypothyroidismGCST902041677.14e-06
11956MYL3 levelsGCST904699777.08e-06
11957Sensorineural hearing lossFING000012917.04e-06
11958SMPD3 levelsGCST904706857.02e-06
11959HypertensionGCST904681356.98e-06
11960KIF22 levelsGCST904696826.98e-06
11961Mean platelet volume during first trimester of pregnancyGCST903022296.97e-06
11962Doctor diagnosed hayfever or allergic rhinitis | Medical informationUKBB000001926.86e-06
11963Blood cell traits latent factor 5 (platelet)GCST905592476.85e-06
11964Alkylphosphatidylcholine (O-32:1) levelsGCST900249236.76e-06
11965IDP dMRI ProbtrackX L1 ilf rGCST900042616.64e-06
11966CLEC4D levelsGCST904687736.55e-06
11967Type 2 diabetes with renal manifestations (PheCode 250.22)GCST904756706.49e-06
11968Types of physical activity in last 4 weeks - None of the above | Physical activityUKBB000008726.44e-06
11969Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T258ECGA0002586.41e-06
11970GFRA2/IL12A_IL12B ratioGCST903149256.38e-06
11971CEP43/TIA1 ratioGCST903140216.37e-06
11972MSTN levelsGCST904699536.34e-06
11973Other systemic involvement of connective tissue (FG)FING000011166.23e-06
11974lymphocyte (absolute count, maximum, inv-norm transformed)GCST904754236.21e-06
11975ACY1 levelsGCST904682126.18e-06
11976ADM levelsGCST904682466.11e-06
11977NFATC1 levelsGCST904700336.08e-06
11978Lifetime number of sexual partners | Sexual factorsUKBB000004066.07e-06
11979Type 1 diabetesGCST900005296.06e-06
11980Personality disorders (more control exclusions)FING000011636.04e-06
11981CRTAP levelsGCST904688726.04e-06
11982DNM3 levelsGCST904690226.04e-06
11983Fasting glucoseGCST900022326.00e-06
11984Telomere length (principal component 1)GCST904351445.93e-06
11985SLAMF7 levelsGCST904706515.93e-06
11986CASP8/RILP ratioGCST903136575.81e-06
11987IL12A_IL12B/LAG3 ratioGCST903151475.75e-06
11988EBAG9/TBCC ratioGCST903145685.75e-06
11989EDAR/ERBIN ratioGCST903145755.66e-06
11990Neutrophil percentage of white cellsGCST900023995.62e-06
11991T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 119)GCST903209385.61e-06
11992Hypertension (PheCode 401)GCST904759195.51e-06
11993FUT8/PDGFA ratioGCST903148905.50e-06
11994TMSB10/TXNRD1 ratioGCST903159255.46e-06
11995Acute appendicitis, with complicationsFING000000195.39e-06
11996aseg lh volume CaudateGCST900026215.37e-06
11997Treatment/medication code - lansoprazole | MedicationsUKBB000008485.34e-06
11998Number of non-cancer illnesses (weighted GWA)GCST902672915.30e-06
11999General happiness | Happiness and subjective well-beingUKBB000002805.27e-06
12000aparc-a2009s rh area S-postcentralGCST900034375.25e-06